Insights

Recent Acquisition858 Therapeutics recently acquired Gotham Therapeutics, expanding its portfolio and capabilities in RNA-focused biotech. This acquisition presents potential cross-selling opportunities to offer a broader range of innovative therapies to customers.

Series B FundingReceiving $50 million in Series B funding showcases investor confidence in 858 Therapeutics' research and development. This funding can be leveraged to scale up sales and marketing efforts to reach a wider customer base.

Biotech Hub LocationSituated in San Diego, a prominent biotech hub, 858 Therapeutics benefits from proximity to top investigators and scientific talent. Leveraging this location can open doors for partnerships and collaborations with other industry players.

Experienced LeadershipFounded by a veteran team with a successful track record in pharma and biotech drug discovery, 858 Therapeutics boasts strong leadership. Utilizing the expertise of this team can help drive strategic sales initiatives and navigate the competitive landscape effectively.

Innovative Tech StackWith a tech stack including Google Analytics, Firebase, and Google Cloud, 858 Therapeutics demonstrates a commitment to leveraging technology for research and development. Sales teams can use data-driven insights from these tools to tailor offerings and enhance customer engagements.

858 Therapeutics Tech Stack

858 Therapeutics uses 8 technology products and services including Firebase, Google Cloud, Lua, and more. Explore 858 Therapeutics's tech stack below.

  • Firebase
    Database
  • Google Cloud
    Infrastructure As A Service
  • Lua
    Programming Languages
  • HSTS
    Security
  • HTTP/3
    Web & Portal Technology
  • X-Content-Type-Options
    Web & Portal Technology
  • Nginx
    Web Servers
  • OpenResty
    Web Servers

858 Therapeutics's Email Address Formats

858 Therapeutics uses at least 1 format(s):
858 Therapeutics Email FormatsExamplePercentage
FLast@8five8tx.comJDoe@8five8tx.com
50%
FLast@8five8tx.comJDoe@8five8tx.com
50%

Frequently Asked Questions

Where is 858 Therapeutics's headquarters located?

Minus sign iconPlus sign icon
858 Therapeutics's main headquarters is located at 3115 Merryfield Row San Diego, California 92121 US. The company has employees across 2 continents, including North AmericaAsia.

What is 858 Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
858 Therapeutics's official website is 8five8tx.com and has social profiles on LinkedIn.

How much revenue does 858 Therapeutics generate?

Minus sign iconPlus sign icon
As of January 2025, 858 Therapeutics's annual revenue reached $1.8M.

What is 858 Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
858 Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does 858 Therapeutics have currently?

Minus sign iconPlus sign icon
As of January 2025, 858 Therapeutics has approximately 30 employees across 2 continents, including North AmericaAsia. Key team members include Chief Executive Officer: J. S.Chief Scientific Officer: J. V.Head Of Program Management And Leadership: A. V.. Explore 858 Therapeutics's employee directory with LeadIQ.

What industry does 858 Therapeutics belong to?

Minus sign iconPlus sign icon
858 Therapeutics operates in the Biotechnology Research industry.

What technology does 858 Therapeutics use?

Minus sign iconPlus sign icon
858 Therapeutics's tech stack includes FirebaseGoogle CloudLuaHSTSHTTP/3X-Content-Type-OptionsNginxOpenResty.

What is 858 Therapeutics's email format?

Minus sign iconPlus sign icon
858 Therapeutics's email format typically follows the pattern of . Find more 858 Therapeutics email formats with LeadIQ.

How much funding has 858 Therapeutics raised to date?

Minus sign iconPlus sign icon
As of January 2025, 858 Therapeutics has raised $50M in funding. The last funding round occurred on Sep 26, 2024 for $50M.

When was 858 Therapeutics founded?

Minus sign iconPlus sign icon
858 Therapeutics was founded in 2019.
858 Therapeutics

858 Therapeutics

Biotechnology ResearchCalifornia, United States11-50 Employees

858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule drugs that act on novel therapeutic targets in oncology.

858 was founded by a veteran team who together bring a track record of success in pharma and biotech drug discovery. Building from our collective experience in the fields of epigenetics, single cell genomics, and innate immunity, 858 scientists are dedicated to the company’s mission to discover innovative therapeutics for the treatment of cancers that are resistant to current therapies.

858 is headquartered in the biotech hub of San Diego, CA, and maintains lab operations in both San Diego and New York City, providing proximity to leading investigators and scientific talent on both coasts of the US.

Section iconCompany Overview

Headquarters
3115 Merryfield Row San Diego, California 92121 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
11-50

Section iconFunding & Financials

  • $50M

    858 Therapeutics has raised a total of $50M of funding over 3 rounds. Their latest funding round was raised on Sep 26, 2024 in the amount of $50M.

  • $10M

    858 Therapeutics's revenue is in the range of $10M

Section iconFunding & Financials

  • $50M

    858 Therapeutics has raised a total of $50M of funding over 3 rounds. Their latest funding round was raised on Sep 26, 2024 in the amount of $50M.

  • $10M

    858 Therapeutics's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.